ilmscore | Prediction Details
"some of them might replace 70% of what they lose in rev limit some companies might at best replace 100% of what they lose in rev limit but it's somewhere between 50 to 100% of what you lose you will be able to replace but you will not probably offset more than what rev limit is giving to"
By Groww | April 24, 2025 | Pending
From video
Sensex, Nifty rally pauses; FMCG & realty stocks fall | Tariff-proofing your pharma portfolio 00:24:07 - 00:24:26
Interpreted Prediction
After generic Revlimid expiry (Jan 2026), companies are predicted to replace 50-100% of their lost revenue through new complex product approvals, but not exceed the original Revlimid contribution.

Prediction Details

Topic
Pharma Sector (Generic Revlimid Revenue Replacement)

Comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.